Institute receives Platinum Green Impact Award for 2020/21
The Cancer Research UK Cambridge Institute has achieved Platinum in the University’s Green Impact Awards.
Green Impact is the University of Cambridge’s environmental accreditation scheme. It supports and encourages departments and colleges across the University in reducing their environmental impacts.
With support from the Environment and Energy Section, departments can form a small team, who sign up to an online workbook and progress through simple, clear and easy criteria towards recognised awards and targets.
Over the last year, our Green Impact team has been working hard to implement new green initiatives within the building, including green procurement agreements, supporting biodiversity onsite, introducing new recycling systems, and creating a pledge programme for staff. Many thanks to the team members: Grace Davison, Cathy Pauley, Emma Wright, Chloe Cashman, Amy Cullen, Beverly Bernhardt, Allan Lui and Colin Weir.
The auditor said “The team has done excellent work in embedding sustainability across the department. The actions taken were well planned and clearly communicated, with evidence of enthusiastic participation from the department. Well done everyone!”
The Institute continues to be fully committed to reducing our impact on the environment wherever possible.
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more